Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesar E Ercole

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
European Urology|May 28, 2015
Survival and Functional Stability in Chronic Kidney Disease Due to Surgical Removal of Nephrons: Importance of the New Baseline Glomerular Filtration RateBrian R Lane, Sevag Demirjian, Ithaar H Derweesh, et al.
Urology|April 21, 2015
Analysis of Atrophy After Clamped Partial Nephrectomy and Potential Impact of IschemiaZhiling Zhang, Cesar E Ercole, Erick M Remer, et al.
Urology|October 24, 2015
Functional Recovery From Extended Warm Ischemia Associated With Partial NephrectomyZhiling Zhang, Juping Zhao, Lily Velet, et al.
Urologic Oncology|December 24, 2014
Presurgical sunitinib reduces tumor size and may facilitate partial nephrectomy in patients with renal cell carcinomaBrian R Lane, Ithaar H Derweesh, Hyung L Kim, et al.
Urologic Oncology|November 1, 2025
Diagnostic performance of Cxbladder Triage Plus for the identification and stratification of patients at risk for urothelial carcinoma: The multicenter, prospective, observational DRIVE studyStephen J Savage, Cesar E Ercole, George Hemstreet, et al.
World Journal of Urology|August 20, 2015
Clinical and therapeutic factors associated with adverse pathological outcomes in clinically node-negative patients treated with neoadjuvant cisplatin-based chemotherapy and radical cystectomyKamran Zargar-Shoshtari, Homayoun Zargar, Colin P Dinney, et al.
The American Journal of Managed Care|January 17, 2018
Improving risk stratification among veterans diagnosed with prostate cancer: impact of the 17-gene prostate score assayJulie A Lynch, Megan P Rothney, Raoul R Salup, et al.
Cancer Medicine|July 7, 2022
Identifying and overcoming barriers to participation of minority populations in clinical trials: Lessons learned from the VanDAAM studyAngelina K C Fink, Amanda C DeRenzis, Shivanshu Awasthi, et al.
Journal of the National Cancer Institute|September 2, 2022
Genomic Testing in Localized Prostate Cancer Can Identify Subsets of African Americans With Aggressive DiseaseShivanshu Awasthi, G Daniel Grass, Javier Torres-Roca, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
A Prospective Validation of the Decipher Genomic Classifier in Men With Early Localized Prostate Cancer: The VANDAAM StudyKosj Yamoah, Purvish Trivedi, Shivanshu Awasthi, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
European Urology|May 28, 2015
Survival and Functional Stability in Chronic Kidney Disease Due to Surgical Removal of Nephrons: Importance of the New Baseline Glomerular Filtration RateBrian R Lane, Sevag Demirjian, Ithaar H Derweesh, et al.
Urology|April 21, 2015
Analysis of Atrophy After Clamped Partial Nephrectomy and Potential Impact of IschemiaZhiling Zhang, Cesar E Ercole, Erick M Remer, et al.
Urology|October 24, 2015
Functional Recovery From Extended Warm Ischemia Associated With Partial NephrectomyZhiling Zhang, Juping Zhao, Lily Velet, et al.
Urologic Oncology|December 24, 2014
Presurgical sunitinib reduces tumor size and may facilitate partial nephrectomy in patients with renal cell carcinomaBrian R Lane, Ithaar H Derweesh, Hyung L Kim, et al.
Urologic Oncology|November 1, 2025
Diagnostic performance of Cxbladder Triage Plus for the identification and stratification of patients at risk for urothelial carcinoma: The multicenter, prospective, observational DRIVE studyStephen J Savage, Cesar E Ercole, George Hemstreet, et al.
World Journal of Urology|August 20, 2015
Clinical and therapeutic factors associated with adverse pathological outcomes in clinically node-negative patients treated with neoadjuvant cisplatin-based chemotherapy and radical cystectomyKamran Zargar-Shoshtari, Homayoun Zargar, Colin P Dinney, et al.
The American Journal of Managed Care|January 17, 2018
Improving risk stratification among veterans diagnosed with prostate cancer: impact of the 17-gene prostate score assayJulie A Lynch, Megan P Rothney, Raoul R Salup, et al.
Cancer Medicine|July 7, 2022
Identifying and overcoming barriers to participation of minority populations in clinical trials: Lessons learned from the VanDAAM studyAngelina K C Fink, Amanda C DeRenzis, Shivanshu Awasthi, et al.
Journal of the National Cancer Institute|September 2, 2022
Genomic Testing in Localized Prostate Cancer Can Identify Subsets of African Americans With Aggressive DiseaseShivanshu Awasthi, G Daniel Grass, Javier Torres-Roca, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
A Prospective Validation of the Decipher Genomic Classifier in Men With Early Localized Prostate Cancer: The VANDAAM StudyKosj Yamoah, Purvish Trivedi, Shivanshu Awasthi, et al.
Pageof 3